Prostate-specific antigen screening and prostate cancer mortality: implications of a randomized European study

By Uhlman Matthew A   Moul Judd W   Robertson Cary N   Sun Leon  

Aging Health, Vol. 5, Iss. 3, 2009-06 ,pp. : 281-286

Future Medicine

Access to resources Recommend Favorite

Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy

By Huang Shu-Pin   Bao Bo-Ying   Wu Ming-Tsang   Choueiri Toni K.   Goggins William B.   Liu Chia-Chu   Huang Chao-Yuan   Pu Yeong-Shiau   Yu Chia-Cheng   Wu Tony T.   Huang Chun-Nung   Huang Chun-Hsiung   Wu Wen-Jeng  

The Aging Male, Vol. 15, Iss. 1, 2012-03 ,pp. : 34-41

Informa Healthcare

Access to resources Recommend Favorite

Screening for prostate cancer in the elderly

By Martinez Roxanne   Wilson Shandra  

Aging Health, Vol. 9, Iss. 4, 2013-08 ,pp. : 359-360

Future Medicine

Access to resources Recommend Favorite

Should elderly men be screened for prostate cancer?

By Moul Judd W   Mouraviev Vladimir  

Aging Health, Vol. 4, Iss. 5, 2008-10 ,pp. : 443-446

Future Medicine

Access to resources Recommend Favorite

Gender matters: health beliefs of women as a predictor of participation in prostate cancer screening among African American men

By Gash Jean   McIntosh Gregory V.  

Diversity and Equality in Health and Care, Vol. 10, Iss. 1, 2013-02 ,pp. : 23-30

Radcliffe Press

Access to resources Recommend Favorite